-
Product Insights
NewHindustan Organic Chemicals Kochi Complex, India
Empower your strategies with our Hindustan Organic Chemicals Kochi Complex, India report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain a gateway to actionable insights and competitive advantage. Acquire a thorough understanding...
-
Product Insights
Innovations in Organ Preservation Equipment – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Organ Preservation Equipment - Global Pipeline Summary" provides comprehensive information about the Organ Preservation Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Organ Preservation Equipment report provides key information and data related to: Extensive coverage of the Organ Preservation Equipment under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental...
-
Innovation Ranking
Innovation Ranking – Hellenic Telecommunications Organization SA
Hellenic Telecommunications Organization SA (OTE) provides fixed and mobile telephony services. The company offers voice, broadband, internet access on 3G and 4G networks; television services; broadband and internet access services; satellite communication; and other related services. It also develops commercial spaces and telecom equipment. The company provides real estate and professional training services. The company also renders financing, e-commerce, retail, wholesale broadband and infrastructure services, electronic money services, ICT and marketing services through its subsidiaries. The company caters its services...
-
Product Insights
NewHeart Transplant Rejection – Drugs In Development, 2024
Empower your strategies with our Heart Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Heart transplantation is the therapy used to treat various heart diseases by replacing an injured or diseased heart with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplantation, the immune system may consider the transplanted heart as foreign and may work against it. Patients may hence develop complications and eventually reject the...
-
Product Insights
NewLiver Transplant Rejection – Drugs In Development, 2024
Empower your strategies with our Liver Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Liver transplantation is the conventional therapy used in various liver diseases. The liver has the unique ability to regenerate or regrow. Liver transplantation replaces an injured or diseased liver with a healthy one; an entire liver or just a section may be transplanted. Following a transplant, the immune system may consider the transplanted liver as foreign and may work against it....
-
Product Insights
NewLung Transplant Rejection – Drugs In Development, 2024
Empower your strategies with our Lung Transplant Rejection – Drugs In Development, 2024 report and make more profitable business decisions. Lung transplantation is the therapy used in various lung diseases. A lung transplant replaces an injured or diseased lung with a healthy one. Risk factors associated with transplantation are bleeding, infection, clots, and cardiovascular disorders. Following a transplant, the immune system may consider the transplanted lung as foreign and may work against it. Patients may hence develop complications and eventually reject...
-
Product Insights
NewAdenocarcinoma – Drugs In Development, 2024
Empower your strategies with our Adenocarcinoma – Drugs In Development, 2024 report and make more profitable business decisions. Adenocarcinoma is a type of cancer that starts in mucus-producing (glandular) cells. Many organs have these types of cells and adenocarcinoma can develop in any of these organs. The symptoms of adenocarcinoma will depend on which organ is affected by cancer. The patients may not experience any symptoms until the cancer is more advanced. The Adenocarcinoma drugs in development market research report provide...
-
Product Insights
NewGlucagon Like Peptide 2 Receptor – Drugs In Development, 2024
The Glucagon Like Peptide 2 Receptor pipeline drugs market research report outlays comprehensive information on the Glucagon Like Peptide 2 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Gastrointestinal, Immunology, Metabolic Disorders, and Other Diseases which include indications of Short Bowel Syndrome, Crohn's Disease (Regional Enteritis), Graft Versus Host Disease (GVHD), Inflammation, Obesity, Unspecified Metabolic Disorders,...
-
Product Insights
NewBurkitt Lymphoma – Drugs In Development, 2024
Empower your strategies with our Burkitt Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Burkitt lymphoma is an aggressive and fast-growing type of non-Hodgkin lymphoma (NHL) that primarily affects B cells, a type of white blood cell involved in the immune system. It is named after Denis Burkitt, a surgeon who described the disease in African children in the 1950s. There are three main types of Burkitt lymphoma. Endemic Burkitt lymphoma is most commonly found in...